Biochemical and pharmacological properties of reporter systems and nanoparticles: For better tumors imaging and treatment

Abstract

Reporter systems can analyze the biochemical and molecular processes in viable cells and organs and help imaging of cancer. That includes gene transcription activity, protein–protein interactions, sub-cellular localization and proteases activities. This helps studying the aspects of neoplastic trans¬formation, drug development, monitoring specific cancer-related events and tracing complex patho¬logical events (angiogenesis, apoptosis, proto-oncogene activity, oncongenes, tumor suppressor genes and tumor promoting signals). Resolution and sensitivity govern the choice of reporters. Nanoparticles have diverse uses (magnetic, catalytic, optical, thermodynamic, and electrochemical). Nanoparti¬cles include aptamers, quantum dots, core-shell silica particles, gold nanoparticles, carbon nanotubes, liposomes, dendrimers, oligonucleotides and magnetic nanoparticles. Superparamagnetic iron oxide nanoparticles (SPIONs) have the advantages of easy visualization using Magnetic resonance imaging (MRI), easy cellular targeting, possibility of generating hyperthermia, and easy biodegradation into metabolizable iron particles. Magnetic nanoparticles can be used in chemotherapy, magnetic hyper¬thermia, photodynamic therapy and photothermal therapy. MRI is the most valuable noninvasive imaging techniques to overcome magnetic nanoparticles colloidal instability. In conclusion, SPIONs are among the best nanoparticles to date owing to their easy visualization using MRI, easy cellular targeting, possibility of generating hyperthermia, and easy biodegradation into metabolizable iron particles. Research regarding reporter systems and nanoparticles is quite interesting and challenging. More research efforts are needed to optimize in vivo cancer imaging and therapeutics monitoring.

References

1. 1.Serganova, I., and Blasberg, R. G. (2019) Molecular imaging with reporter genes: has its promise been delivered?, Journal of Nuclear Medicine 60, 1665-1681.
2. 2.Yang, D. J., Kim, E. E., and Inoue, T. (2006) Targeted molecular imaging in oncology, Annals of nuclear medicine 20, 1-11.
3. 3.Massoud, T. F., and Gambhir, S. S. (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light, Genes & development 17, 545-580.
4. 4.Sharpless, N. E., and DePinho, R. A. (2006) The mighty mouse: genetically engineered mouse models in cancer drug development, Nature reviews Drug discovery 5, 741-754.
5. 5.Lowik, C., Cecchini, M., Maggi, A., 124 Majmaah Journal of Health Sciences ,Vol. 11, Issue 4 , October - 2023, Rabi’Al-Awwal - 1445 Biochemical and pharmacological properties of reporter systems and nanoparticles: For better tumors imaging and treatment and van der Pluijm, G. (2005) Noninvasive Real-Time In Vivo Bloluminescent Imaging of Gene Expression and of Tumor Progression and Metastasis, Molecular Imaging, 193-227.
6. 6.Genove, G., DeMarco, U., Xu, H., Goins, W. F., and Ahrens, E. T. (2005) A new transgene reporter for in vivo magnetic resonance imaging, Nature medicine 11, 450-454.
7. 7.Zhu, C., Li, L., Wang, Z., Irfan, M., and Qu, F. (2020) Recent advances of aptasensors for exosomes detection, Biosensors and Bioelectronics 160, 112213.
8. 8.Ellwood-Yen, K., Wongvipat, J., and Sawyers, C. (2006) Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens, Cancer Research 66, 10513-10516.